Bortezomib and daratumumab in refractory autoimmune hemolytic anemia.
Am J Hematol
; 98(10): E263-E265, 2023 10.
Article
in En
| MEDLINE
| ID: mdl-37417424
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Anemia, Hemolytic, Autoimmune
/
Multiple Myeloma
Limits:
Humans
Language:
En
Journal:
Am J Hematol
Year:
2023
Type:
Article
Affiliation country:
United States